킵스파마

256940KOSDAQ의약품 제조업

43.9 / 100

Reference Date: 2026-06-10

Financial Score10.5 / 40

News Sentiment20.4 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Plunged 15.7% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Kipsis Pharma operates three main business segments: OLED equipment development and supply, battery recycling, and pharmaceutical manufacturing and sales. In the OLED segment, the company is expanding its global market through high-precision equipment and FMM mask development. The recycling segment produces lead ingots from recycled batteries for supply to battery manufacturers. Additionally, the biopharma segment is gaining growth momentum through the development of anticancer drugs and digital therapeutics.

Number of Employees

96people

Average Salary

55.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 11.934.0Point

PBR

1.51Industry Average 0.891.0Point

1.7x industry avg (risky)

ROE

-14.33Industry Average 4.010.0Point

Well below industry avg

Debt Ratio

77.31Industry Average 12.430.0Point

6.2x industry avg (risky)

Trend 2023~20255.5 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲35.9% (2-year basis)

Operating Profit Growth Rate

2.5 / 3

Avg ▲14.2% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -1.8% (declining, 3yr)

Detailed News Sentiment

6 totalPositive 6Neutral 0Negative 0Average Sentiment Score 81.7

Positive
킵스파마, 바이오USA 참가…"글로벌 파트너십 확대"
킵스파마의 바이오USA 참가로 글로벌 파트너십 확대 기대감 증가.
Positive
킵스파마, 바이오 USA 참가…빅파마와 항암제·경구 플랫폼 기술협력....
킵스파마의 바이오 USA 참가로 글로벌 제약사들과의 기술 협력 확대 기대.
Positive
킵스파마, 'KB 스몰캡 코퍼레이트 데이' 참가…"기업가치 제고 본격화...
킵스파마가 KB 스몰캡 코퍼레이트 데이에 참가함으로써 기업 가치 제고와 투자자 유치에 긍정적 영향을 기대된다.

Detailed Momentum

52-week position1.0Point

Near 52w low (1%, downtrend)

Current 6,120Won52-week high 20,95052-week low 5,960

1-month return0.0Point

1m -15.70% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0

Neutral기업설명회(IR)개최2026-06-02
Neutral분기보고서 (2026.03)2026-05-15
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-14
Neutral주식등의대량보유상황보고서(일반)2026-05-14